Oliver A. Cornely

1999–2025 年に発表

別表記
Oliver A Cornely
326
論文数
47,298
被引用数
110
h 指数
307
i10 指数

被引用数

Oliver A. Cornely の年別被引用数1989 年: 被引用 1 件1991 年: 被引用 1 件1994 年: 被引用 4 件1999 年: 被引用 1 件2000 年: 被引用 2 件2001 年: 被引用 1 件2002 年: 被引用 4 件2003 年: 被引用 10 件2004 年: 被引用 10 件2005 年: 被引用 27 件2006 年: 被引用 32 件2007 年: 被引用 88 件2008 年: 被引用 113 件2009 年: 被引用 98 件2010 年: 被引用 127 件2011 年: 被引用 116 件2012 年: 被引用 116 件2013 年: 被引用 163 件2014 年: 被引用 218 件2015 年: 被引用 209 件2016 年: 被引用 311 件2017 年: 被引用 313 件2018 年: 被引用 322 件2019 年: 被引用 1,311 件2020 年: 被引用 1,510 件2021 年: 被引用 2,064 件2022 年: 被引用 1,801 件2023 年: 被引用 1,395 件2024 年: 被引用 2,421 件2025 年: 被引用 1,159 件2026 年: 被引用 23 件1990 年は被引用が無いため表示していません1992〜1993 年は被引用が無いため表示していません1995〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,711 件、この内訳の 17.8%ドイツ: 引用元論文 1,055 件、この内訳の 6.9%イギリス: 引用元論文 924 件、この内訳の 6.1%中国: 引用元論文 810 件、この内訳の 5.3%イタリア: 引用元論文 764 件、この内訳の 5%フランス: 引用元論文 758 件、この内訳の 5%スペイン: 引用元論文 665 件、この内訳の 4.4%オランダ: 引用元論文 583 件、この内訳の 3.8%インド: 引用元論文 480 件、この内訳の 3.2%オーストラリア: 引用元論文 451 件、この内訳の 3%カナダ: 引用元論文 417 件、この内訳の 2.7%スイス: 引用元論文 385 件、この内訳の 2.5%
0%17.8%その他 34.3%

分野

  • Medicine78%
  • Biochemistry, Genetics and Molecular Biology10.7%
  • Immunology and Microbiology4.6%
  • Agricultural and Biological Sciences1.2%
  • Environmental Science0.8%
  • Health Professions0.7%
  • その他4%

トピック

  • Antifungal resistance and susceptibility16.6%
  • Fungal Infections and Studies11.2%
  • Clostridium difficile and Clostridium perfringens research3%
  • Antibiotic Resistance in Bacteria2.2%
  • Neutropenia and Cancer Infections2.1%
  • Nail Diseases and Treatments2.1%
  • その他62.8%

共著者

全論文

検索で開く
  1. Tackling the emerging threat of antifungal resistance to human health

    著者: , , , , , , , , , , , , , , , , , , , - Nature Reviews Microbiology 2022 被引用: 1,116

  2. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claus Peter Heußel, C Kibbler, Н Н Климко, Bart Jan Kullberg, Christoph Lange, Thomas Lehrnbecher, Jürgen Löffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Jacques F. Meis, Livio Pagano, Patricia Ribaud, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Maurizio Sanguinetti, Donald C. Sheppard, János Sinkó, Anna Skiada, Maria J. G. T. Vehreschild, Claudio Viscoli, Oliver A. Cornely - Clinical Microbiology and Infection 2018 被引用: 1,518

  3. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús Guinea, Claus Peter Heußel, Ashraf S. Ibrahim, Souha S. Kanj, Н Н Климко, Michaela Lackner, Frédéric Lamoth, Fanny Lanternier, Cornelia Lass-Floerl, Dong‐Gun Lee, Thomas Lehrnbecher, B. Lmimouni, Mihai Mareș, Georg Maschmeyer, Jacques F. Meis, Joseph Meletiadis, C. Orla Morrissey, Márcio Nucci, Rita Oladele, Livio Pagano, Alessandro C. Pasqualotto, Atul Patel, Zdeněk Ráčil, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Seyedmojtaba Seyedmousavi, Neeraj Sidharthan, Nina Singh, János Sinkó, Anna Skiada, Monica A. Slavin, Rajeev Soman, Brad Spellberg, William J. Steinbach, Ban Hock Tan, Andrew J. Ullmann, Jörg Janne Vehreschild, Maria J. G. T. Vehreschild, Thomas J. Walsh, P. Lewis White, Nathan P. Wiederhold, Theoklis E. Zaoutis, Arunaloke Chakrabarti - The Lancet Infectious Diseases 2019 被引用: 1,756

  4. The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

    著者: , , , , , , , , , , , - Drugs 2021 被引用: 441

  5. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 被引用: 953

  6. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 972

  7. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 850

  8. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Romanee Chaiwarith, Methee Chayakulkeeree, Sharon Chen, Yee‐Chun Chen, Yen‐Hsu Chen, Jun Yong Choi, Young Hwa Choi, Darunee Chotiprasitsakul, Jin-Won Chung, François Danion, Blandine Denis, Emilio Diaz Santos, Miguel O Dictar, Marc Diltoer, Hervé Dupont, Sizhou Feng, Maria Angeles Ferre Colomer, Ricard Ferrer, Jean-Marie Fernand Roger Forel, Jesús Fortün, Julia Garcia‐Diaz, Massimo Girardis, Fang He, Maya Hites, Mao‐Wang Ho, Patrick M. Honoré, Juan Pablo Horcajada, Haihui Huang, Po‐Yen Huang, Yong Huang, Osamah Hussein, Poj Intalapaporn, Sutep Jaruratanasirikul, Luis Jáuregui-Peredo, Misty Johnson, Dong Sik Jung, Kamonwan Jutivorakool, Winfried V. Kern, Daniel H. Kett, Thana Khawcharoenporn, Young Keun Kim, Philipp Koehler, Αναστασία Κοτανίδου, Anne M. Lachiewicz, Qinhan Lin, Luis Eduardo López Cortés, Hong Luo, Roberto Luzzati, ‪Yasmin Maor‬‏, Todd P McCarty, Maria Merelli, Paloma Merino Amador, John Midturi, Guglielmo Marco Migliorino, Jean‐Paul Mira, Piroon Mootsikapun, Orla Morrissey, Patricia Muñoz García de Paredes, Cristina Mussini, Eleftherios Mylonakis, Saadalla Nseir, William Nseir, Zekaver Odabaşı, Vasileios Papastamopoulos, David L. Paterson, Thomas F. Patterson, Kyong Ran Peck, Zhiyong Peng, Nitipong Permpalung, Gaëtan Plantefève ほか 42 名 - The Lancet 2022 被引用: 168

  9. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anuradha Chowdhary, Sybren de Hoog, George Dimopoulos, Rafael F. Duarte, Petr Hamal, Jacques F. Meis, Sayoki Mfinanga, Flávio Queiroz‐Telles, Thomas F. Patterson, Galia Rahav, Thomas R. Rogers, Coleman Rotstein, Retno Wahyuningsih, Danila Seidel, Oliver A. Cornely - The Lancet Infectious Diseases 2021 被引用: 432

  10. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernhard Hube, Olaf Kniemeyer, Axel A. Brakhage, C. Schwarz, Alexander Scheffold - Cell 2019 被引用: 483

  11. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2012 被引用: 1,214

  12. Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - Infectious Diseases and Therapy 2018 被引用: 442

  13. Impact of climate change and natural disasters on fungal infections

    著者: , , , , , , , , , , , , , - The Lancet Microbe 2024 被引用: 205

  14. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carolina García‐Vidal, Daniele Roberto Giacobbe, Anna L. Goodman, Petr Hamal, Helena Hammarström, Cristina Toscano, Fanny Lanternier, Cornelia Lass‐Flörl, Deborah Lockhart, Thomas Longval, Laura Loughlin, Tadeja Matos, Małgorzata Mikulska, Manjusha Narayanan, Sonia Martín‐Pérez, Juergen Prattes, Benedict Rogers, Laman Rahimli, Maite Ruiz, Emmanuel Roilides, Michael Samarkos, Ulrike Scharmann, Uluhan Sili, Oğuz Reşat Sıpahı, Alena Siváková, Joerg Steinmann, Janina Trauth, Özge Turhan, Jens Van Praet, Antonio Vena, P. Lewis White, Birgit Willinger, Anna Maria Tortorano, Maiken Cavling Arendrup, Philipp Koehler, Oliver A. Cornely, Mario Tumbarello, Alida Fe Talento, Alba Ruiz‐Gaitán, Zdeněk Ráčil, И. О. Стома, María Calbacho, Eric Van Wijngaerden, Júlia Henriques, Harriett Jordan, Valentina Ferroni, Özlem Koyuncu Özyurt, Christopher Milacek, Robert Krause, Christoph Zurl, Matthijs Backx, Ang Li, Raphael Seufert, Rok Tomazin, Yael Blankenheim, Julio Dávila, Paloma García-Clemente, Tomáš Freiberger, Jochem B. Buil, Jacques F. Meis, Deniz Akyol, Hélène Guegan, Clare Logan - The Lancet Infectious Diseases 2023 被引用: 140

  15. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis

    著者: , , , , , , , - Clinical Microbiology and Infection 2019 被引用: 321

  16. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

    著者: , , , , , , , , , , , , , , , , - The Lancet Microbe 2022 被引用: 435

  17. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Graeme Meintjes, Marisa H. Miceli, Peter‐Michael Rath, Andrej Spec, Flávio Queiroz‐Telles, Ebrahim Variava, Paul E. Verweij, Ilan S. Schwartz, Alessandro C Pasqualotto - The Lancet Infectious Diseases 2021 被引用: 278

  18. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2007 被引用: 1,807

  19. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José-Artur Paiva, Maddalena Peghin, Santi Maurizio Raineri, Riina Rautemaa‐Richardson, Jeroen Schouten, Pierluigi Brugnaro, Herbert Spapen, Polychronis Tasioudis, Jean‐François Timsit, Valentino Tisa, Mario Tumbarello, Charlotte H. S. B. van den Berg, Benoît Veber, Mario Venditti, Guillaume Voiriot, Joost Wauters, Philippe Montravers - Critical Care 2019 被引用: 253

  20. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Özlem Koyuncu Özyurt, Faruk Aydın, Filip Růžička, Eelco F. J. Meijer, Jean‐Pierre Gangneux, Deborah Lockhart, Nina Khanna, Clare Logan, Ulrike Scharmann, Guillaume Désoubeaux, Emmanuel Roilides, Alida Fe Talento, Karin van Dijk, Philipp Koehler, Jon Salmanton‐García, Oliver A. Cornely, Martin Hoenigl - Journal of Infection 2023 被引用: 107

  21. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2020 被引用: 454

  22. The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey

    著者: , , , , , , , , , - The Lancet Microbe 2022 被引用: 93

  23. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carolyn Sasse, Rochelle Maher, Bernhardt Zeiher, Maria J. G. T. Vehreschild - The Lancet Infectious Diseases 2016 被引用: 694

  24. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grégory Jouvion, David B. Meya, David S. Lawrence, Sebastian Rahn, Felix Bongomin, Brendan McMullan, Rosanne Sprute, Tinashe K. Nyazika, Justin Beardsley, Fabianne Carlesse, Christopher H. Heath, Olusola Ayanlowo, Olga Mashedi, Flávio Queiróz-Telles Filho, Mina C. Hosseinipour, Atul Patel, Elvis Temfack, Nina Singh, Oliver A. Cornely, David R. Boulware, Olivier Lortholary, Peter G. Pappas, John R. Perfect - The Lancet Infectious Diseases 2024 被引用: 269